公开(公告)号：US12100498B2

公开(公告)日：2024-09-24

申请号：US17505867

申请日：2021-10-20

Applicant: MEDTRONIC MINIMED, INC.

Inventor： Benyamin Grosman ,  Anirban Roy ,  Patrick E. Weydt ,  Neha J. Parikh ,  Louis J. Lintereur ,  Di Wu

IPC: G16H20/17 ,  A61B5/00 ,  A61B5/145 ,  A61M5/142 ,  A61M5/145 ,  A61M5/168 ,  A61M5/172 ,  G16H10/20 ,  G16H10/60 ,  G16H20/60 ,  G16H40/63 ,  G16H50/20 ,  G16H50/50 ,  A61K38/28 ,  G16H20/30 ,  G16H50/30

CPC classification number: G16H20/17 ,  A61B5/14532 ,  A61B5/4839 ,  A61M5/142 ,  A61M5/14244 ,  A61M5/145 ,  A61M5/16831 ,  A61M5/1723 ,  G16H10/20 ,  G16H10/60 ,  G16H20/60 ,  G16H40/63 ,  G16H50/20 ,  G16H50/50 ,  A61B5/746 ,  A61B5/7465 ,  A61K38/28 ,  A61M2005/14208 ,  A61M5/16804 ,  A61M5/16877 ,  A61M2205/18 ,  A61M2205/3303 ,  A61M2205/35 ,  A61M2205/3569 ,  A61M2205/3584 ,  A61M2205/3592 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2205/8206 ,  A61M2230/201 ,  A61M2230/63 ,  G16H20/30 ,  G16H50/30

Abstract: Disclosed herein are techniques related to configurable target values. The techniques may involve identifying a target glucose value obtained based on user input. Additionally, the techniques may involve determining a fluid delivery command based on a difference between a measured glucose value and the target glucose value. The techniques may further involve causing fluid delivery by a fluid infusion device in accordance with the fluid delivery command to regulate the measured glucose value to the target glucose value.

公开(公告)号：US20240261502A1

公开(公告)日：2024-08-08

申请号：US18611643

申请日：2024-03-20

Applicant: Medtronic MiniMed, Inc.

Inventor： Lavie Golenberg ,  Louis J. Lintereur ,  Benyamin Grosman ,  Di Wu ,  Maria Diana Miller

IPC: A61M5/172 ,  A61B5/00 ,  A61M5/142

CPC classification number: A61M5/1723 ,  A61B5/4809 ,  A61B5/746 ,  A61M5/14248 ,  A61M2205/18 ,  A61M2205/505 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/582 ,  A61M2205/583 ,  A61M2205/587 ,  A61M2205/8206 ,  A61M2230/005 ,  A61M2230/201 ,  A61M2230/63

Abstract: A processor-implemented method for controlling delivery of insulin to a user of an insulin infusion device involves: obtaining user status sensor data indicative of a sleeping status of a user of an insulin infusion device, and controlling operation of the insulin infusion device in accordance with the sleeping status of the user.

公开(公告)号：US11690955B2

公开(公告)日：2023-07-04

申请号：US16856838

申请日：2020-04-23

Applicant: MEDTRONIC MINIMED, INC.

Inventor： Louis J. Lintereur ,  Alexander S. Campbell ,  Dmytro Y. Sokolovskyy ,  Neha J. Parikh ,  Maria Diana Miller

IPC: A61M5/00 ,  A61M5/172 ,  G16H10/40 ,  G16H40/67 ,  G16H20/17

CPC classification number: A61M5/1723 ,  G16H10/40 ,  G16H20/17 ,  G16H40/67 ,  A61M2205/18 ,  A61M2205/3584 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/505 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/582 ,  A61M2205/583 ,  A61M2205/702 ,  A61M2230/201

Abstract: Disclosed is a method of controlling operation of a medical device that regulates delivery of a fluid medication to a user. The method obtains a current sensor-generated value that is indicative of a physiological characteristic of the user, and is produced in response to operation of a continuous analyte sensor device. The method continues by: calculating a sensor quality metric that indicates reliability and trustworthiness of the current sensor-generated value; adjusting, in response to the calculated sensor quality metric, therapy actions of the medical device to configure a quality-specific operating mode of the medical device; managing generation of user alerts at the medical device in response to the calculated sensor quality metric; and regulating delivery of the fluid medication from the medical device, in accordance with the current sensor-generated value and the quality-specific operating mode of the medical device.

公开(公告)号：US20230201451A1

公开(公告)日：2023-06-29

申请号：US18117574

申请日：2023-03-06

Applicant: MEDTRONIC MINIMED, INC.

Inventor： Salman Monirabbasi ,  Louis J. Lintereur ,  Jin Yan

IPC: A61M5/142 ,  A61M5/145 ,  G16H40/40 ,  G16H40/60 ,  A61M5/168 ,  A61M5/172 ,  G16H20/17

CPC classification number: A61M5/14244 ,  A61M5/14526 ,  G16H40/40 ,  G16H40/60 ,  A61M5/16804 ,  A61M5/1723 ,  A61M5/1452 ,  G16H20/17 ,  A61M2005/1726 ,  A61M2205/3379 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2205/58 ,  A61M2230/005 ,  A61M2230/201

Abstract: Techniques disclosed herein relate to managing transitions into fluid delivery device operating modes. In some embodiments, the techniques involve obtaining status information pertaining to operation of a fluid delivery device, the status information including fluid delivery data, exiting a closed-loop operating mode of the fluid delivery device based on the status information, and, after exiting the closed-loop operating mode, causing generation of a user notification recommending a remedial action to improve viability of a subsequent instance of the closed-loop operating mode. The closed-loop operating mode is an operating mode in which dosage commands are automatically generated based on sensor measurement data.

公开(公告)号：US20230121873A1

公开(公告)日：2023-04-20

申请号：US18067417

申请日：2022-12-16

Applicant: Medtronic MiniMed, Inc.

Inventor： Patrick E. Weydt ,  Pratik J. Agrawal ,  Louis J. Lintereur ,  Lavie Golenberg ,  David Dunleavy

IPC: G16H40/67 ,  A61B5/00 ,  A61K38/28 ,  A61M5/142 ,  A61M5/172 ,  G06F3/01 ,  G06N3/08 ,  G16H20/17 ,  G16H20/60 ,  G16H40/20 ,  G16H70/40 ,  H04W4/02 ,  A61B5/145

Abstract: An example system for therapy delivery includes one or more processors configured to in response to a prediction indicating that the meal event is to occur, output instructions to an insulin delivery device to deliver a partial therapy dosage, to a device to notify the patient to use the insulin delivery device to take the partial therapy dosage, or to the insulin delivery device to prepare the partial therapy dosage prior to the meal event occurring, and in response to a determination indicating that the meal event is occurring (e.g., based on movement characteristics of a patient arm), output instructions to the insulin delivery device to deliver a remaining therapy dosage, to the device to notify the patient to use the insulin delivery device to take the remaining therapy dosage, or to the insulin delivery device to prepare the remaining therapy dosage.

公开(公告)号：US20220176039A1

公开(公告)日：2022-06-09

申请号：US17112321

申请日：2020-12-04

Applicant: Medtronic MiniMed, Inc.

Inventor： Louis J. Lintereur ,  Catherine Tan Fogel ,  Patrick E. Weydt ,  Benyamin Grosman ,  Mahta Sadeghzadeh

IPC: A61M5/172 ,  G16H50/20 ,  G16H50/70 ,  G16H50/50 ,  G16H40/20 ,  G16H10/20 ,  G16H40/40 ,  G16H40/67 ,  G06Q30/04 ,  G16H50/30 ,  G16H20/17

Abstract: Devices, systems, and techniques for therapy delivery and healthcare management is described. In one example, a system comprises a delivery device configured to execute therapy information comprising a treatment schedule specifying one or more treatments over a time period, wherein for each of the one or more treatments, the therapy information comprises a treatment type and a treatment amount; and processing circuitry configured to: determine a modification to the therapy information based on a recommendation of a digital twin, wherein the digital twin determines an estimated glucose level expected to be within a healthy range if the delivery device executes the modification to therapy information; and in response to physician review of the modification to the therapy information, output, to a healthcare provider system for the patient, data indicating completion of a healthcare service corresponding to the physician review.

公开(公告)号：US11324881B2

公开(公告)日：2022-05-10

申请号：US16691513

申请日：2019-11-21

Applicant: MEDTRONIC MINIMED, INC.

Inventor： Eric Allan Larson ,  Shixin Chen ,  Magnus Johansson ,  Louis J. Lintereur ,  Austin Reeder ,  Peter Schultz

IPC: A61M5/142

Abstract: A pump for delivering a fluid includes a pump housing that defines at least one reservoir having a circumferentially open first end, a circumferentially closed second end and a chamber to receive the fluid. The pump includes a plunger assembly having at least one plunger arm and a cannula fluidly coupled to the plunger arm to dispense the fluid from the pump. The plunger arm is receivable within the first end of the reservoir, and the at least one plunger arm defining an internal conduit to receive the fluid from the at least one fluid reservoir. The internal conduit is fluidly coupled to the cannula. The plunger assembly is movable in a first direction relative to the pump housing to advance the plunger arm within the fluid reservoir to dispense the fluid from the fluid reservoir out of the pump via the cannula.

公开(公告)号：US20220105268A1

公开(公告)日：2022-04-07

申请号：US17065500

申请日：2020-10-07

Applicant: MEDTRONIC MINIMED, INC.

Inventor： Mahta Sadeghzadeh ,  Salman Monirabbasi ,  Dmytro Y. Sokolovskyy ,  Louis J. Lintereur ,  Alexander S. Campbell

IPC: A61M5/172 ,  G06F3/0484 ,  G06T11/00

Abstract: Methods, computer-readable medium, and devices that provide a graphic user interface for operating a medical infusion system are described. An exemplary method includes receiving analyte level information for a user; and providing a graphic user interface on a display element that includes an analyte level chart depicting analyte values and an infusate delivery chart. An exemplary chart depicts graphics showing basal amounts of infusate delivered by the system over time, wherein each graphic is illustrated with a dimension indicating an increased, same, or decreased amount relative to an immediately preceding graphic. Further, the exemplary chart depicts indicators showing bolus amounts delivered by the medical infusion system over time, wherein at least a portion of the bolus indicators is illustrated with a dimension not to scale.

公开(公告)号：US20210398639A1

公开(公告)日：2021-12-23

申请号：US17336912

申请日：2021-06-02

Applicant: Medtronic MiniMed, Inc.

Inventor： Anirban Roy ,  Benyamin Grosman ,  Louis J. Lintereur ,  Peter Onesti ,  Di Wu ,  Neha J. Parikh

IPC: G16H20/17 ,  G16H20/60 ,  G06N3/08 ,  A61M5/172

Abstract: The present disclosure relates to default carbohydrate consumption counts based on population carbohydrate consumption models. Aspects of the present disclosure relate to receiving, from a device, at least one characteristic of a person; accessing a population carbohydrate consumption model which relates the at least one characteristic with carbohydrate intake for a population; determining, based on applying the population carbohydrate consumption model to the at least one characteristic, at least one of: a preliminary carbohydrate count for the person or a default carbohydrate consumption count for the person; and causing delivery of insulin to the person based on communicating, to the device, at least one of: the preliminary carbohydrate count for the person or the default carbohydrate consumption count for the person.

公开(公告)号：US11158413B2

公开(公告)日：2021-10-26

申请号：US16386104

申请日：2019-04-16

Applicant: MEDTRONIC MINIMED, INC.

Inventor： Benyamin Grosman ,  Di Wu ,  Louis J. Lintereur ,  Anirban Roy ,  Neha J. Parikh ,  Patrick E. Weydt ,  Ali Dianaty

IPC: G16H20/17 ,  A61M5/172 ,  A61B5/00 ,  A61M5/142

Abstract: A medical device system and related method of automatically adjusting parameters of an insulin delivery controller of an insulin infusion device are disclosed. The methodology obtains therapy-related data associated with operation of the insulin infusion device for a number of days in the past, including sensor glucose data associated with glucose levels of the user, and meal data associated with identified meals. The obtained therapy-related data is processed to generate a suitable pharmacokinetic/pharmacodynamic (PK/PD) model of the user, wherein the PK/PD model fits at least some of the sensor glucose data obtained for the user. The PK/PD model can be used to calculate at least one adjusted parameter of the insulin delivery controller, based on additional therapy-related data associated with further operation of the insulin infusion device. The insulin delivery controller can be instructed or controlled to adjust its settings in accordance with the model-calculated parameters.